Point Designs Unveils Merge MID: A Groundbreaking Body-Powered Prosthesis Revolutionizing Care for Partial Finger Amputations on November 18, 2026 Posted by
Empowering Philanthropy: A Strategic Guide to Supporting Cancer Research and Patient Advocacy on November 17, 2026 Posted by
Beyond the Pour: Massive Study Uncovers Complex Links Between Alcohol Types and Longevity on November 17, 2026 Posted by
The Trojan Horse of Hematology: Marrow Therapeutics Emerges with $173 Million to Revolutionize Bone Marrow Medicine on November 17, 2026 Posted by
Beyond the CPAP: Understanding the Role of GLP-1s in Managing Obstructive Sleep Apnea on November 17, 2026 Posted by
Roche’s New Breast Cancer Drug Wilserdly Receives FDA Approval: A New Era for Oral SERDs on November 17, 2026 Posted by
Point Designs Unveils Merge MID: A Groundbreaking Body-Powered Prosthesis Revolutionizing Care for Partial Finger Amputations on November 18, 2026 Posted by
Empowering Philanthropy: A Strategic Guide to Supporting Cancer Research and Patient Advocacy on November 17, 2026 Posted by
Beyond the Pour: Massive Study Uncovers Complex Links Between Alcohol Types and Longevity on November 17, 2026 Posted by
The Trojan Horse of Hematology: Marrow Therapeutics Emerges with $173 Million to Revolutionize Bone Marrow Medicine on November 17, 2026 Posted by
Posted in Medical Innovations The Precision Revolution: ai3Bio Emerges with $48M to Redefine Autoimmune Treatment on September 30, 2026
Posted in Medical Innovations The Future of Autoimmune Therapy: Adicet Bio’s Gamma Delta Approach Challenges the CAR-T Status Quo on September 29, 2026
Posted in Medical Innovations Amgen’s Dazodalibep Hits Milestone in High-Stakes Sjögren’s Trial: A New Frontier for Autoimmune Care on September 23, 2026
Posted in Digital Health Tools Bridging the Gap in Chronic Care: Ayble Health Secures $16M Series A to Revolutionize Digestive and Autoimmune Health on September 18, 2026
Posted in Digital Health Tools Transparency Under Fire: The CAR-T Autoimmune Crisis and the Push for Clinical Accountability on September 4, 2026
Posted in Medical Innovations The High-Stakes Pivot: Autoimmune Cell Therapy Faces a Critical Reality Check on September 2, 2026
Posted in Digital Health Tools A Breakthrough in Hematology: Johnson & Johnson’s Imaavy Secures First-Ever FDA Approval for Warm Autoimmune Hemolytic Anemia on September 2, 2026
Posted in Medical Innovations Safety Setback: Big Pharma Halts CAR T-Cell Trials for Autoimmune Diseases Following Fatalities on September 1, 2026
Posted in Medical Innovations Setback in the "Immune Reset" Frontier: Novartis and Bristol Myers Pause CAR-T Autoimmune Trials on August 31, 2026
Posted in Cancer Recovery Beyond Cancer: Could CAR T-Cell Therapy Rewrite the Future of Autoimmune Treatment? on August 30, 2026